Chris Kilham, Medicine Hunter, welcomes you to the Ashwagandha Experience, an educational program brought to you by WholeFoods Magazine and KSM-66 Ashwagandha. Ashwagandha Experience will include videos, white papers, deep dives, infographics, blogs, and interviews, in order to bring you the latest science, formulation guidance, sustainability information, supply chain updates,...
Los Angeles, CA—Supplementing with KSM-66 Ashwagandha root extract for eight weeks led to significant improvement in sleep quality parameters in both healthy and insomniac patients, in a new study published in the Journal of Ethnopharmacology. The study looked at 80 patients in a double-blind, randomized, placebo-controlled, parallel group, stratified, comparative...
Los Angeles, CA—Health Canada has granted a new set of health claims for Ixoreal Biomed's KSM-66 Ashwagandha root extract ingredient. The company announced that, under Health Canada’s NPN (Natural Product Number) 80102381 and its accompanying license, formulators using KSM-66 can make new claims related to memory enhancement, sleep, energy, stress,...
Los Angeles, CA—KSM-66 Ashwagandha can be a safe, effective solution to insomnia and the anxiety that accompanies it, according to a new double-blind, randomized, placebo-controlled human clinical study published in Cureus. According to a press release on the topic, 60 subjects with insomnia were randomized in a 2:1 ratio to...
Los Angeles, CA—NutraIngredients Asia handed out their “Ingredient of the Year: Sports Nutrition” award to Ixoreal BioMed for their KSM-66 at their conference in Singapore. KSM-66 is, according to Ixoreal BioMed, the most bioavailable ashwagandha on the world market. The editor-in-chief of NutraIngredients, Gary Scattergood, said that “The awards were...
Los Angeles, CA – Ixoreal Biomed Inc., the manufacturer of KSM-66 ashwagandha extract, has expanded a suit against Sensoril producer Natreon and its distributor NutraGenesis, claiming false patent marking, defamation, product disparagement and tortious interference. The new claims this week are on top of an earlier countersuit Ixoreal Biomed filed...
